Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort.

Saleh, Rasha N M; Hornberger, Michael; Ritchie, Craig W; Minihane, Anne Marie

Saleh, Rasha N M; Hornberger, Michael; Ritchie, Craig W; Minihane, Anne Marie.

Affiliation

Saleh RNM; Norwich Medical School, University of East Anglia, Norwich, UK. r.saleh@uea.ac.uk.
Hornberger M; Norwich Medical School, University of East Anglia, Norwich, UK.
Ritchie CW; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Minihane AM; Norwich Medical School, University of East Anglia, Norwich, UK.

Alzheimers Res Ther ; 15(1): 10, 2023 01 09.

Article in En | MEDLINE | ID: mdl-36624497

Subject(s)

Alzheimer Disease; Female; Humans; Alzheimer Disease/diagnostic imaging; Alzheimer Disease/genetics; Alzheimer Disease/prevention & control; Apolipoprotein E4/genetics; Cognition/physiology; Genotype; Hormone Replacement Therapy; Prospective Studies; Temporal Lobe/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Alzheimer Disease Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Alzheimers Res Ther Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google